BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Mar 21, 2026; 32(11): 117149
Published online Mar 21, 2026. doi: 10.3748/wjg.v32.i11.117149
Figure 1
Figure 1 Kaplan-Meier analysis of time to wound healing in the modified Hu-Lian-Bi-Guan decoction group compared with the control group. mHLBGD: Modified Hu-Lian-Bi-Guan decoction.
Figure 2
Figure 2 Histopathological results of postoperative wound tissue in two groups (hematoxylin-eosin staining). Low-power (left, scale bar = 20 μm) and high-power (right, scale bar = 10 μm). mHLBGD: Modified Hu-Lian-Bi-Guan decoction.
Figure 3
Figure 3 Comparison of mRNA expression of inflammatory cytokines, TGF-β/Smad signaling molecules, and epithelial-mesenchymal transition markers in two groups. aP < 0.05. Pre: Pre-treatment; Post: Post-treatment; mHLBGD: Modified Hu-Lian-Bi-Guan decoction; N-cad: N-cadherin; VIM: Vimentin; E-cad: E-cadherin.
Figure 4
Figure 4 Comparison of protein expression levels of inflammatory cytokines, TGF-β/Smad signaling molecules, and epithelial-mesenchymal transition markers in two groups. A: Relative protein expression levels of each group; B: Western blot analysis of wound tissue protein expression. aP < 0.05. Pre: Pre-treatment; Post: Post-treatment; Con: Control; mHLBGD: Modified Hu-Lian-Bi-Guan decoction; N-cad: N-cadherin; VIM: Vimentin; E-cad: E-cadherin.